Becton, Dickinson and Co. | BDX - Pe Kurs-Gewinn

Aktienkurs
149.52
Täglich Wechseln
-0.70 -0.47%
Monatlich
-3.34%
Jährlich
-27.57%
Q2 Prognose
148.88




Pe Veränderung Datum
Abbott 24.94 5.78 2026-03
Agilent 25.04 2.13 2025-12
Align Technology 19.74 1.58 2025-12
AngioDynamics 8.82 1.6 2024-03
Avanos Medical 126.82 119.59 2025-12
Baxter International 17.1 4.46 2025-09
Becton, Dickinson and Co. 17.68 114.67 2025-12
Bio-Rad Laboratories 16.42 17.1 2025-09
Boston Scientific 32.35 5.17 2026-03
Cooper Companies 40.27 15.78 2025-12
Danaher 29.29 10.39 2026-03
Dentsply International 29.99 15.81 2025-12
Dexcom 32.18 3.28 2025-12
Edwards Lifesciences 26.86 4.76 2026-03
Globus Medical 25.06 6.24 2025-12
Insulet 55.08 5.63 2025-12
Integra LifeSciences 6.58 0.5 2025-12
Intuitive Surgical 55.82 15.79 2026-03
J&J 24.53 0.91 2026-03
Masimo 32.44 71.8 2025-12
Medtronic 22.76 1.32 2025-12
Solventum Corp 5.89 79.35 2025-12
Stryker 32.13 2.69 2025-12
Tandem Diabetes Care 681.05 189.32 2022-03
Teleflex 27.79 16.3 2025-12
Terumo 23.28 2.98 2025-09
Thermo Fisher Scientific 27.71 3.29 2026-03
Zimmer Biomet Holdings 17.91 3.5 2025-12